Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
February 5, 2025 2:09 PM 3 min read

Bill Ackman Sends UnitedHealth Stock Lower With Deleted Tweet: Here's What He Said

by Chris Katje Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

Hedge fund manager Bill Ackman sent shares of UnitedHealth Group (NYSE:UNH) lower with a tweet alleging overstated profits, which comes as the health insurance company faces more scrutiny after the death of an executive.

What Happened: The health insurance sector faces pressure after the killing of UnitedHealthcare CEO Brian Thompson put a bigger spotlight on potentially high claim denial rates, with the alleged murderer accusing the company of prioritizing profits over people.

Ackman stirred further concerns for UnitedHealth Group with a tweet on Tuesday night.

"I would not be surprised to find that the company's profitability is massively overstated due to its denial of medically necessary procedures and patient care," Ackman said in the since-deleted tweet.

Ackman suggested he would short the stock if he still shorted stocks.

The hedge funder called on the SEC to investigate UnitedHealth Group.

Now, Ackman himself could face an SEC probe. The insurance company said they contacted the SEC with concerns about Ackman's post, as reported by Bloomberg.

"Health insurance has long been subject to significant regulatory oversight and earnings caps," UnitedHealth said in a statement.

The company said that people like Ackman claiming that insurance companies "can somehow over-earn are grossly misinformed."

Read Also: Buffett, Musk, Wood, Cuban Or Ackman: Who Do Investors Trust Most With Life Savings? Poll Shows It Isn’t Even Close

Why It's Important: Ackman's assertion that profitability was "massively overstated" follows the company’s Jan. 16 earnings report.

The company has faced many questions about its profitability and its claims approval and denial process as alleged killer Luigi Mangione allegedly targeted Thompson and UnitedHealth due to the company's position in the health insurance sector.

UnitedHealthcare is the largest individual player in Medicare Advantage with 7.8 million members, the company’s latest earnings report revealed. The company also has 4.3 million members enrolled in Medicare supplement plans through UnitedHealthcare. It also has 3 million people enrolled in standalone Part D coverage.

Thompson’s death and the possible motive behind his killing have drawn scrutiny to the health insurance sector, including reports of high claim denial rates by companies like UnitedHealth Group.

UnitedHealth CEO Andrew Witty acknowledged the pressure on the health insurance sector during the company’s earnings call. The industry needs to be “less confusing, less complex and less costly” for patients, he said.

Mangione faces New York state charges along with federal charges. He also faces the potential of the death penalty if found guilty of first-degree murder on federal charges.

Mangione pleaded not guilty in New York on Dec. 23. He is expected to appear in federal court on Feb. 21.

UNH, DIA Price Action: UnitedHealth stock is down 1.6% to $536.70 on Wednesday. Shares hit a daily low of $521.91 before recovering slightly. The stock has traded between $436.38 and $630.73 over the past year.

The quick drop in UnitedHealth stock to open Wednesday's trading session also saw ETFs that track the Dow Jones Industrial Average like the SPDR Dow Jones Industrial ETF (NYSE:DIA) fall.

The SPDR Dow Jones Industrial ETF fell to start the day before recovering. The ETF is now up 0.3% on the day at the time of writing.

UnitedHealth is the second largest holding in the Dow Jones ETF and the second largest weighting of the index, which weighs stocks by stock price and not market capitalization.

Read Next:

  • Luigi Mangione Documentaries In The Works From Award-Winning Creators — And Possibly Rapper 50 Cent

Image created using artificial intelligence via Midjourney.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
MoversTrading IdeasInsuranceBill AckmanBrian ThompsonDow Jones Industrial AverageHealth Insuranceinsurance stocksSECStories That Matter
UNH Logo
UNHUnitedHealth Group Inc
$277.900.31%
Overview
DIA Logo
DIAState Street SPDR Dow Jones Industrial Average ETF Trust
$469.000.33%
UNH Logo
UNHUnitedHealth Group Inc
$277.900.31%
Overview
DIA Logo
DIAState Street SPDR Dow Jones Industrial Average ETF Trust
$469.000.33%
Comments
Loading...